GLP-1² is an exclusive next-generation formulation that synergistically combines semaglutide and tirzepatide—two of the most advanced GLP-1 receptor agonists—in one powerful treatment. Available only through DrWell Providers, GLP-1² represents a new frontier in clinical care for sustainable weight loss, improved metabolic control, and total wellness transformation.
GLP-1² brings together two potent active ingredients that work on complementary pathways:
Semaglutide is a GLP-1 receptor agonist known for its appetite regulation and glucose-lowering effects.
Tirzepatide is a dual GIP/GLP-1 receptor agonist that not only curbs hunger but enhances insulin sensitivity and energy metabolism.
By combining these two, GLP-1² offers a dual-action approach that maximizes metabolic benefits, supporting faster and more sustained results than either molecule alone.
This advanced therapy is designed for individuals struggling with weight management, insulin resistance, or metabolic syndrome—and seeking a medically supervised, science-backed solution.
Accelerated weight loss through dual appetite suppression and increased satiety
Enhanced glycemic control, ideal for patients with prediabetes or Type 2 diabetes
Improved metabolic flexibility, supporting fat oxidation and reduced insulin resistance
Reduced cravings and stabilized energy levels, leading to better adherence and quality of life
Longer therapeutic coverage, minimizing blood sugar spikes and hunger throughout the day
GLP-1² is a prescription-only formulation and must be administered under the supervision of a licensed DrWell Provider. As with all GLP-1 therapies, there are important safety considerations:
Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
May cause nausea, vomiting, diarrhea, especially during dose titration
Monitor for signs of pancreatitis, gallbladder issues, or allergic reactions
Avoid concurrent use with other GLP-1 agonists unless directed by a medical provider
Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders
Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes.
GLP-1² is not available in pharmacies or over-the-counter. This unique formulation is custom compounded and dispensed only to patients enrolled in a medically supervised program through DrWell Providers. This ensures the highest standard of care, safety, and results-driven outcomes.
